How NMNH Skips Rate-Limiting Enzymes to Redefine NAD+ Synthesis Prepared for: R&D Strategy Teams, Nutraceutical Formulators, and Biotechnology Buyers Date: April 20, 2026 Source: Rainwood Biotech Scientific Communications Series 1. The NAD+ Arms Race...
VIEW MORE
Executive SummaryThe landscape of longevity science is characterized by rapid evolution. For nearly a decade, Nicotinamide Mononucleotide (NMN) has dominated the discourse as the primary vehicle for NAD+ restoration. However, scientific advancement i...
VIEW MORE
Executive Summary In the global landscape of longevity supplements, '99.9% Purity' is often treated as the ultimate metric of quality. However, for a molecule as sensitive as Beta-Nicotinamide Mononucleotide, a factory-gate analysis is merely the beg...
VIEW MORE
Executive Summary In the 2026 wellness market, 'purity' is no longer the final goal—it is the baseline. High-end brands are now pivoting away from chemically synthesized NMN due to concerns over solvent residues and biological activity. This re...
VIEW MORE
Executive Summary In the high-stakes global supply chain for Beta-Nicotinamide Mononucleotide, the line between a primary manufacturer and a sophisticated broker has become dangerously blurred. This audit provides a forensic approach to procurement, ...
VIEW MORE
Executive Summary In the NMN industry, purity is the price of entry, but bulk density is the key to longevity. This audit explores why low-density NMN is a 'ticking time bomb' for stability and how Rainwood Biotech’s engineered crystals ($>0.6g...
VIEW MORE
Executive Summary In the longevity market, purity is often treated as the ultimate metric. However, for Beta-Nicotinamide Mononucleotide, the real challenge is not purity, but the 'Gastric Barrier.' This audit exposes why 70% of standard NMN capsules...
VIEW MORE
Executive Summary The regulatory frost surrounding NMN has officially thawed. As we enter 2026, the global market for Beta-Nicotinamide Mononucleotide is shifting from 'underground sourcing' to 'mainstream pharmaceutical-grade dominance.' This strate...
VIEW MORE
Executive Summary As Shilajit's popularity skyrockets, a dangerous 'Shadow Industry' has emerged—creating synthetic resins from coal tar, humic fertilizers, and ozokerite. These toxic substitutes are designed to mimic the appearance of Himalaya...
VIEW MORE
Executive Summary In the high-stakes world of premium supplements, "Himalayan" origin has become a shorthand for quality. However, for QA managers and brand owners, this geographic label often masks a catastrophic supply chain vulnerability: Phthalat...
VIEW MORE
Executive Summary In the Shilajit market, consumers and brands are often divided between the 'Traditional Resin' and the 'Convenient Powder.' This audit explores the molecular differences between these forms, exposing the 'Carrier Trap' found in 95% ...
VIEW MORE
Executive Summary Shilajit is a geological product, meaning it is born in close contact with rock minerals—including Lead and Arsenic. For brands aiming for the US market, this is a lethal risk. This audit explores how Rainwood Biotech’s ...
VIEW MORE
EN